BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 9570509)

  • 1. Regulation of equine infectious anemia virus expression.
    Maury W
    J Biomed Sci; 1998; 5(1):11-23. PubMed ID: 9570509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phorbol ester stimulation of equine macrophage cultures alters expression of equine infectious anemia virus.
    Sellon DC; Walker KM; Russell KE; Perry ST; Fuller FJ
    Vet Microbiol; 1996 Oct; 52(3-4):209-21. PubMed ID: 8972047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocyte maturation controls expression of equine infectious anemia virus.
    Maury W
    J Virol; 1994 Oct; 68(10):6270-9. PubMed ID: 8083967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equine endothelial cells support productive infection of equine infectious anemia virus.
    Maury W; Oaks JL; Bradley S
    J Virol; 1998 Nov; 72(11):9291-7. PubMed ID: 9765477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic quasispecies associated with the initiation of infection and disease in ponies experimentally infected with equine infectious anemia virus.
    Lichtenstein DL; Issel CJ; Montelaro RC
    J Virol; 1996 Jun; 70(6):3346-54. PubMed ID: 8648664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular and viral specificity of equine infectious anemia virus Tat transactivation.
    Maury WJ; Carpenter S; Graves K; Chesebro B
    Virology; 1994 May; 200(2):632-42. PubMed ID: 8178449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony.
    Leroux C; Issel CJ; Montelaro RC
    J Virol; 1997 Dec; 71(12):9627-39. PubMed ID: 9371627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic characterization by composite sequence analysis of a new pathogenic field strain of equine infectious anemia virus from the 2006 outbreak in Ireland.
    Quinlivan M; Cook F; Kenna R; Callinan JJ; Cullinane A
    J Gen Virol; 2013 Mar; 94(Pt 3):612-622. PubMed ID: 23175240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of long terminal repeat sequence variation on equine infectious anemia virus replication in vitro and in vivo.
    Lichtenstein DL; Craigo JK; Leroux C; Rushlow KE; Cook RF; Cook SJ; Issel CJ; Montelaro RC
    Virology; 1999 Oct; 263(2):408-17. PubMed ID: 10544113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Horses naturally infected with EIAV harbor 2 distinct SU populations but are monophyletic with respect to IN.
    Cervantes DT; Ball JM; Edwards J; Payne S
    Virus Genes; 2016 Feb; 52(1):71-80. PubMed ID: 26739458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of equine infectious anemia viral RNA in plasma samples from recently infected and long-term inapparent carrier animals by PCR.
    Langemeier JL; Cook SJ; Cook RF; Rushlow KE; Montelaro RC; Issel CJ
    J Clin Microbiol; 1996 Jun; 34(6):1481-7. PubMed ID: 8735102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localized sequence heterogeneity in the long terminal repeats of in vivo isolates of equine infectious anemia virus.
    Maury W; Perryman S; Oaks JL; Seid BK; Crawford T; McGuire T; Carpenter S
    J Virol; 1997 Jul; 71(7):4929-37. PubMed ID: 9188555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional replacement and positional dependence of homologous and heterologous L domains in equine infectious anemia virus replication.
    Li F; Chen C; Puffer BA; Montelaro RC
    J Virol; 2002 Feb; 76(4):1569-77. PubMed ID: 11799151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replication ability in vitro and in vivo of equine infectious anemia virus avirulent Japanese strain.
    Zheng YH; Sentsui H; Sugita M; Nakaya T; Kishi M; Hagiwara K; Inoshima Y; Ishihara C; Kono Y; Lu JL; Ikuta K
    Virology; 2000 Jan; 266(1):129-39. PubMed ID: 10612667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long terminal repeat sequences from virulent and attenuated equine infectious anemia virus demonstrate distinct promoter activities.
    Zhou T; Yuan XF; Hou SH; Tu YB; Peng JM; Wen JX; Qiu HJ; Wu DL; Chen HC; Wang XJ; Tong GZ
    Virus Res; 2007 Sep; 128(1-2):58-64. PubMed ID: 17499380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell specificity of the transcription-factor repertoire used by a lentivirus: motifs important for expression of equine infectious anemia virus in nonmonocytic cells.
    Maury W; Bradley S; Wright B; Hines R
    Virology; 2000 Feb; 267(2):267-78. PubMed ID: 10662622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of the equine infectious anemia virus long terminal repeat during the alteration of cell tropism.
    Maury W; Thompson RJ; Jones Q; Bradley S; Denke T; Baccam P; Smazik M; Oaks JL
    J Virol; 2005 May; 79(9):5653-64. PubMed ID: 15827180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of LTR and structural genes in an equine infectious anemia virus strain isolated from a feral horse in Japan.
    Dong J; Cook FR; Haga T; Horii Y; Norimine J; Misawa N; Goto Y; Zhu W
    Arch Virol; 2014 Dec; 159(12):3413-20. PubMed ID: 25149072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue sites of persistent infection and active replication of equine infectious anemia virus during acute disease and asymptomatic infection in experimentally infected equids.
    Harrold SM; Cook SJ; Cook RF; Rushlow KE; Issel CJ; Montelaro RC
    J Virol; 2000 Apr; 74(7):3112-21. PubMed ID: 10708426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of EIAV LTR variability and compartmentalization in various reservoir tissues of long-term inapparent carrier ponies.
    Reis JK; Craigo JK; Cook SJ; Issel CJ; Montelaro RC
    Virology; 2003 Jun; 311(1):169-80. PubMed ID: 12832214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.